Skip to main content
logo
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
10.04
-0.19 (-1.86%)
At close: Aug 21, 2026, 4:00 PM EDT
10.20
+0.16 (1.59%)
After-hours: Aug 21, 2026, 7:37 PM EDT

Cartesian Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-151.89-130.3-77.42-219.7135.38-25.69
Depreciation & Amortization
2.612.961.150.841.291.25
Loss (Gain) From Sale of Assets
--0.270.48-0.15-
Asset Writedown & Restructuring Costs
56.756.77.580.71--
Loss (Gain) From Sale of Investments
22--0.08-0.380.06
Stock-Based Compensation
9.2410.526.5822.5211.197.72
Other Operating Activities
-0.02-7.7643.96139.1-18.594.47
Change in Accounts Receivable
0.16-0.247.980.910.16-2.69
Change in Accounts Payable
0.371.07-2.932.830.09-0.22
Change in Unearned Revenue
---5.855.26-64.71-45.5
Change in Income Taxes
-----0.60.6
Change in Other Net Operating Assets
4.3-8.89-4.99-4.034.68-0.39
Operating Cash Flow
-76.53-73.94-23.67-51.16-31.63-60.38
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.08-5.45-9.09-0.21-1.2-1.09
Sale of Property, Plant & Equipment
--0.35---
Cash Acquisitions
---6.56--
Investment in Securities
---28.25-13.8-16.06
Investing Cash Flow
-2.08-5.45-8.7434.61-15-17.14

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
----27.46--
Net Debt Issued (Repaid)
46.03---27.46--
Issuance of Common Stock
20.040.32128.490.2339.3352.9
Other Financing Activities
-0.15-8.38-0.07-6.17-0.11-
Financing Cash Flow
65.93-8.06168.43-13.1539.2252.9

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.030.05-0.02-0.050.02-0
Net Cash Flow
-12.72-87.41135.99-29.75-7.4-24.63

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-78.61-79.4-32.77-51.37-32.83-61.47
Free Cash Flow Growth
------
Free Cash Flow Margin
-5322.41%-2838.58%-84.21%-197.53%-29.64%-72.25%
Free Cash Flow Per Share
-2.90-3.06-1.89-9.94-6.75-16.13
Levered Free Cash Flow
-47.48-55.62-59.6728.9122.24-
Unlevered Free Cash Flow
-46.95-55.62-59.6730.6824.13-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---1.852.252
Change in Working Capital
4.83-8.06-5.794.97-60.38-48.19
SEC Filings: 10-K · 10-Q